世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6000
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・過敏性腸症候群（IBS）処方薬の市場動向
・企業の競争状況、市場シェア
・過敏性腸症候群（IBS）処方薬の種類別市場規模と予測2016-2027（IBS-D薬、IBS-C薬、その他）
・過敏性腸症候群（IBS）処方薬の用途別市場規模と予測2016-2027（女性用、男性用）
・過敏性腸症候群（IBS）処方薬の北米市場規模2016-2027（アメリカ、カナダ）
・過敏性腸症候群（IBS）処方薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・過敏性腸症候群（IBS）処方薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・過敏性腸症候群（IBS）処方薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・過敏性腸症候群（IBS）処方薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Ironwood Pharmaceuticals、Bausch Health、Takeda、Sebela Pharmaceuticals、Allergan）
・結論

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months.

Market Analysis and Insights: Global Rx Irritable Bowel Syndrome (IBS) Drugs Market
The global Rx Irritable Bowel Syndrome (IBS) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rx Irritable Bowel Syndrome (IBS) Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rx Irritable Bowel Syndrome (IBS) Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rx Irritable Bowel Syndrome (IBS) Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rx Irritable Bowel Syndrome (IBS) Drugs market.

Global Rx Irritable Bowel Syndrome (IBS) Drugs Scope and Market Size
Rx Irritable Bowel Syndrome (IBS) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rx Irritable Bowel Syndrome (IBS) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
IBS-D Drugs
IBS-C Drugs
Others

Segment by Application
Women
Men

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IBS-D Drugs
1.2.3 IBS-C Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Perspective (2016-2027)
2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Regions
2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Industry Dynamic
2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
2.3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
2.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
2.3.4 Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue
3.1.1 Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Revenue (2016-2021)
3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue
3.4 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio
3.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2020
3.5 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
3.6 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
3.7 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Type
4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Type (2016-2021)
4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2022-2027)

5 Rx Irritable Bowel Syndrome (IBS) Drugs Breakdown Data by Application
5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Historic Market Size by Application (2016-2021)
5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
6.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
6.2.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
6.2.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
6.2.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
6.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
6.3.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
6.3.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
6.3.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
6.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
6.4.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
6.4.2 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
7.2.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
7.2.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
7.2.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
7.3.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
7.3.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
7.3.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
7.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
7.4.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
7.4.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
8.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
8.2.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
8.3.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region
8.4.1 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
9.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
9.2.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
9.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
9.3.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
9.4 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
9.4.1 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2016-2027)
10.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
10.2.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
10.3.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country
10.4.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Ironwood Pharmaceuticals Business Overview
11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
11.1.5 Ironwood Pharmaceuticals Recent Development
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
11.2.5 Bausch Health Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Sebela Pharmaceuticals
11.4.1 Sebela Pharmaceuticals Company Details
11.4.2 Sebela Pharmaceuticals Business Overview
11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
11.4.5 Sebela Pharmaceuticals Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
11.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
11.5.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IBS-D Drugs
Table 3. Key Players of IBS-C Drugs
Table 4. Key Players of Others
Table 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2016-2021)
Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2022-2027)
Table 11. Rx Irritable Bowel Syndrome (IBS) Drugs Market Trends
Table 12. Rx Irritable Bowel Syndrome (IBS) Drugs Market Drivers
Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Market Challenges
Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Market Restraints
Table 15. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players (2016-2021)
Table 17. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2020)
Table 18. Ranking of Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product Solution and Service
Table 22. Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ironwood Pharmaceuticals Company Details
Table 63. Ironwood Pharmaceuticals Business Overview
Table 64. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 65. Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
Table 66. Ironwood Pharmaceuticals Recent Development
Table 67. Bausch Health Company Details
Table 68. Bausch Health Business Overview
Table 69. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 70. Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
Table 71. Bausch Health Recent Development
Table 72. Takeda Company Details
Table 73. Takeda Business Overview
Table 74. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 75. Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
Table 76. Takeda Recent Development
Table 77. Sebela Pharmaceuticals Company Details
Table 78. Sebela Pharmaceuticals Business Overview
Table 79. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 80. Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
Table 81. Sebela Pharmaceuticals Recent Development
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product
Table 85. Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021) & (US$ Million)
Table 86. Allergan Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type: 2020 VS 2027
Figure 2. IBS-D Drugs Features
Figure 3. IBS-C Drugs Features
Figure 4. Others Features
Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application: 2020 VS 2027
Figure 6. Women Case Studies
Figure 7. Men Case Studies
Figure 8. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
Figure 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2022-2027)
Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Players in 2020
Figure 14. Global Top Rx Irritable Bowel Syndrome (IBS) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Rx Irritable Bowel Syndrome (IBS) Drugs Revenue in 2020
Figure 16. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
Figure 20. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
Figure 21. North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
Figure 22. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
Figure 26. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
Figure 27. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
Figure 28. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Region (2016-2027)
Figure 38. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Rx Irritable Bowel Syndrome (IBS) Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Ironwood Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
Figure 58. Bausch Health Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
Figure 60. Sebela Pharmaceuticals Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

以下、関連資料のご紹介

下痢を伴う過敏性腸症候群（IBS-D）薬のグローバル市場調査 2019年

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Professional Survey Report 2019
QYR9NV07075 2019年11月12日 108Pages
※本調査レポートは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、序文、エルキサドリン、アロセトロン、リファキシミン...

便秘薬による過敏性腸症候群のグローバル市場調査 2019年

Global Irritable Bowel Syndrome with Constipation Drugs Market Professional Survey Report 2019
QYR9NV07074 2019年11月12日 103Pages
※本調査レポートは、便秘薬による過敏性腸症候群の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他...

過敏性腸症候群（IBS）のグローバル市場2021

Global Irritable Bowel Syndrome (IBS) Sales Market Report 2021
QAF27753 2021年4月6日 134Pages
本市場調査資料では、世界の過敏性腸症候群（IBS）市場について種類別（IBS-D薬、IBS-C薬、その他）、用途別（女性、男性）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤ...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年）

Global Inflammatory Bowel Disease Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4364 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、炎症性腸疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（潰瘍性大腸炎、クローン病、その他）、用途別市場規模（病院、医学研究機構、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の慢性疲労症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Chronic Fatigue Syndrome Drug Market Size, Status and Forecast 2021-2027
QFJ1-5659 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、慢性疲労症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤＆NSAID、抗うつ薬＆抗精神病薬、抗菌薬＆免疫調節薬）、用途別市場規模（病院、小売薬局、その他）、主要地域別市場規模（北米、...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の炎症性腸疾患体外診断市場規模・現状・予測（2021年-2027年）

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Size, Status and Forecast 2021-2027
QFJ1-4397 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、炎症性腸疾患体外診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アッセイ/バイオマーカー、アナライザー）、用途別市場規模（診断研究所、病院、研究機関）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

下痢を伴う過敏性腸症候群（IBS-D）薬のグローバル市場調査 2019年 The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level,…
便秘薬による過敏性腸症候群のグローバル市場調査 2019年 The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Constipation Drugs volume and value at global level, regiona…
過敏性腸症候群（IBS）のグローバル市場2021 Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predomin…
ドライアイ症候群薬のグローバル市場調査 2019年 The global Dry Eye Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Dry Eye Syndrome Drugs volume and value at global level, regional level and company level. From a global perspective…
ギランバレー症候群薬のグローバル市場調査 2019年 The global Guillain-Barre Syndrome Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Guillain-Barre Syndrome Drugs volume and value at global level, regional level and company level. From a glob…